|
Delayed
TEL AVIV STOCK EXCHANGE
02:13:41 21/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1,420.00 ILa | -1.11% |
|
-5.90% | -12.24% |
| 09/09 | InterCure Regains Nasdaq Compliance | MT |
| 25/08 | InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Farming
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.5Cr | - | - | - | - | - |
| 12TCr | |||||
| 10TCr | |||||
| 5.85TCr | - | ||||
| 2.62TCr | |||||
| 2.62TCr |
- Stock Market
- Stocks
- INCR Stock
- Charts InterCure Ltd.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
